CBI HCP Engagement, Data Validation and Reporting Conference offers senior-level executives the opportunity to adapt to the evolving landscape and transition as spend reporting becomes an intricate piece of HCP interaction.
The conference will take place on November 18-19, 2014 at the Hyatt in Bellevue, Philadelphia, Pennsylvania
Join industry leaders and identify challenges behind the intricacies of tracking and documenting data, understand how to coordinate medical affairs and compliance teams for reporting HCP spend and develop innovations in KOL engagement and mapping. In addition discover solutions with other decision-makers surrounding compensation and FMV, as well as compare how to address physicians’ reactions to the first data report.
Thomas Sullivan President of Rockpointe will be presenting: “Examine Sunshine Act New CME Rule and the Effect on Engagement.” He will examine how transfers of value for CME is currently required under Sunshine and how the CMS payment rule may change that.
This session explores if this new policy will affect pharma’s strategy moving forward with CME programs and how these programs may affect the interaction with other functions at drug and medical device companies.
The session will also offer:
- Benchmarking on how organizations responded to CMS
- Discussion on whether the rule will have an effect on the perception of CME programming
Other presentations at the conference will address how to:
- Measure the impact of both traditional and non-traditional emerging opinion leaders
- Utilize data to calculate the efficacy of virtual engagements
- Identify best practices to handling physician disputes, data collection and reporting
- Explore technology and digital solutions for more streamlined interactions
- Examine CMS’ new proposed rule to remove the reporting exemption for CME programming
- Assess the impact public disclosure has on establishing FMV